Abstract
The peptide hormone angiotensin II is the main effector of the renin angiotensin system and may be involved in the pathogenesis of several cardiovascular diseases such as congestive heart failure and hypertension. Drugs developed to inhibit angiotensin II effects such as angiotensin-converting enzyme (ACE) inhibitors or receptor antagonists helped to detect the cardiovascular and cellular mechanisms of angiotensin II effects. ACE inhibitor effects are complex and include indirect as well as direct mechanisms. Indirect effects are mediated by unloading the heart via prevention of aldosterone release and modulation of sympathetic nervous system activity. Direct actions include the inhibition of cardiac fibroblast proliferation and collagen synthesis as well as hypertrophy of cardiomyocytes. Recent work has focused on uncovering the biochemical and molecular mechanisms of angiotensin II induced cell growth.
Similar content being viewed by others
References
Baker KM, Booz GW, Dostal DE (1992) Cardiac actions of angiotensin II. Role of an intracardiac renin-angiotensin system. Ann Rev Physiol. 54: 227–241
Bhat GJ, Thekkumkara TJ, Thomas WG, Conrad KM, Baker KM (1994) Angiotensin II stimulated sis-inducing factor-like DNA binding activity. J Biol Chem 269: 31443–31449
Brilla CG, Janicki JS, Weber KT (1991) Cardioreparative effects of lisinopril in rats with genetic hypertension and left ventricular hypertrophy. Circulation 83: 1771–1779
Chen RH, Sarnecki C, Blenis J (1992) Nuclear localisation and regulation of erk-and rsk-encoded protein kinases. Mol Cell Biol 12: 915–927
Crozier J, Ikram H, Awan N (1995) Losatan in heart failure: hemodynamic effects and tolerability. Circulation 91: 691–697
Darnell JE, Kerr IM, Stark GR (1994) Jak-Stats pathways and transcriptional activation in response to INF's and other extracellular signal proteins. Science 264: 1415–1421
Feigl LA (1993) The many roads that lead to ras. Science 260: 767–768
Force T, Kyriakis JM, Avruch J, Bonventre JV (1991) Endothelin, vasopressin, and angiotensin II enhance tyrosine phosphorylation by protein kinase cascade dependent and independent pathways in glomerular mesangial cells. J Biol Chem 266: 6650–6656
Gottlieb SS, Dickstein K, Fleck E, Kostis J, Levine TB, LeJemel TH, DeKock M (1993) Hemodynamic and neurohumeral effects of angiotensin II antagonist losartan in patients with congestive heart failure. Circulation 88: 1602–1609
Hu K, Gaudron P, Anders JH, Wiedemann F, Kruse B, Ertl G (1994) Angiotensin-converting enzyme inhibition (Quinapril) or angiotensin II receptor blockade (Losartan) on hemodynamics and remodeling in rats after experimental myocardial infarction. Circulation 90, Suppl II: I-467
Huckle WR, Prokop CA, Dy RC, Herman B, Earp S (1990) Angiotensin II stimulates protein-tyrosine phosphorylation in a calcium dependent manner. Mol Cell Biol 10: 6290–6298
Hunter T, Cooper JA (1985) Proteintyrosine kinases. Annu Rev Biochem 54: 897–939
Jalil JE, Janicki JS, Pick R, Weber KT (1990) Coronary vascular remodeling and myocardial fibrosis in the rat with renovascular hypertension: response to captopril. Am J Hypertens 4: 51–55
Kahawara Y, Sunako M, Tsuda T, Fukuzaki H, Fukumoto Y (1988) Angiotensin II induces expression of the c-fos gene through protein kinase C activation and calcium ion mobilisation in cultured vascular smooth muscle cells. Biochem Biophys Res Comun 50: 52–59
Marrero MB, Schieffer B, Paxton WG, Heerdt L, Berk BC, Delafontaine P, Bernstein KE (1995) Direct stimulation of Jak/Stat pathway by the angiotensin II AT1 receptor. Nature 375: 247–250
Molloy CJ, Taylor DS, Weber H (1993) Angiotensin II stimulation of rapid protein tyrosine phosphorylation and protein kinase activation in rat aortic smooth muscle cells. J Biol Chem 268: 7338–7345
Morgan HE, Baker KM (1991) Cardiac Hypertrophy. Mechanical, neuronal and endocrine dependence. Circulation 83: 13–26
Naftilan AJ, Pratt RE, Dzau VJ (1989) Induction of platelet-derived growth factor A-chain and c-myc gene expressions by angiotensin II in cultured rat vascular smooth muscle cells. J Clin Invest 83: 1419–1424
Naftilan AL, Gretchen K, Gilliland K, Eldridge CS, Kraft A (1990) Induction of proto-oncogene c-jun by angiotensin II. Mol Cell Biol 11: 5536–5540
Pelicci G, Lanfrancone L, Grignani F, McGlade J, Cavallo F, Forni G, Nicoletti I, Grinani F, Pawson T, Pelicci PG (1992) A novel transforming protein (SHC) with an SH2 domain is implicated in mitogenic signal transduction. Cell 70: 93–104
Rapp UR, Bruder JT, Troppmaier J (1994) The role of raf-signal transduction pathway in fos-jun regulation and determination of cell faith. In Angel PE, Herrlich PA (eds) Fos and jun families of transcription factors, CRC Press, pp 221–247
Sadochima J, Qui Z, Morgan JP, Izumo S (1994) Angiotensin II and other hypertrophic stimuli mediated by G-proteincoupled receptors activated tyrosine kinase, mitogen-activated protein kinase, and 90 kDa S6 kinase in cardiac myocytes. Circ Res 76: 1–15
Schelling P, Ganten D, Speack G, Fischer H (1979) Effects of angiotensin II and angiotensin II antagonist saralasin on cell growth and renin in 3T3 and SV3T3 cells. J Cell Physiol. 98: 503–513
Schorb W, Booz GW, Dostal DE, Conrad KM, Chang KC, Baker KM, (1993) Angiotensin II is mitogenic in neonatal rat cardiac fibroblasts. Circ Res 72: 1245–1254
Schorb W, Peeler TC, Madigan NN, Conrad KM, Baker KM (1994) Angiotensin II-induced protein tyrosine phosphorylation in neonatal rat cardiac fibroblasts. J Biol Chem 269: 19626–19632
Schorb W, Conrad KM, Singer HA, Dostal DE, Baker KM (1995) Angiotensin II is a potent stimulator of MAP-kinase activity in neonatal rat cardiac fibroblasts. J Mol Cell Cardiol 27: 1151–1160
Solvd Investigators (1991) Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 325: 293–302
Taubman MB, Brk BC, Izumo S, Tsuda T, Alexander RW, Nadal-Ginard B (1989) Angiotensin II induces c-fos mRNA in aortic smooth muscle: role of Ca2+ mobilisation and protein kinase C activation. J Bio Chem 264: 526–530
Tsuda T, Kahawara Y, Ishida Y, Koide M, Shii K, Yokohama M (1992) Angiotensin II stimulates two myelin basic protein/microtubule-associated protein 2 kinases in cultured vascular smooth muscle cells. Circ Res 71: 620–630
VanKrimpen C, Smits JFM, Cleutjens JPM, Debets JJM, Shoemaker RG, Struyker Boudier HAJ, Bosman FT, Maemen MJAP (1991) DNA synthesis in the non-infarcted cardiac interstitium after left coronary artery ligation in the rat: Effects of captopril. J Mol Cell Cardiol 23: 1245–1253
Villareal FJ, Kim NN, Ungab GD, Prinz MP, Dillmann WH (1993) Identification of functional angiotensin II receptors on rat cardiac fibroblasts. Circulation 88: 2849–2861
Weber KT, Sun Y, Katwa LC, Cleutjens JPM (1995) Connective tissue: a metabolic entity? J Mol Cell Cardiol 27: 107–120
Yamazaki T, Tobe K, Hoh E, Meamura K, Kaida T, Komuro I, Tamemoto H Kakashi T, Nagai R, Yazaki Y (1993) Mechanical loading activates mitogenactivated protein kinase and S6 peptide kinase in cultured rat cardiac myocytes. J Biol Chem 16: 12069–12076
Yamazaki T, Komuro I, Yazaki Y (1995) Molecular mechanism of cardiac cellular hypertrophy by mechanical stress. J Mol Cell Cardiol 27: 133–140
Zachary I, Sinneth-Smith J, Rozengurt E (1992) Bombesin, vasopressin, and endothelin stimulation of tyrosine phosphorylation in Swiss 3T3 cells. J Biol Chem 267: 19031–19034
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Schorb, W., Ertl, G. Angiotensin II Type 1 receptor induced signal-transduction pathways as new targets for pharmacological treatment of the renin-angiotensin system. Basic Res Cardiol 91 (Suppl 1), 91–96 (1996). https://doi.org/10.1007/BF00795369
Issue Date:
DOI: https://doi.org/10.1007/BF00795369